These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 29215532)
1. IMAGING OF VITELLIFORM MACULAR LESIONS USING POLARIZATION-SENSITIVE OPTICAL COHERENCE TOMOGRAPHY. Deák GG; Schmidt WM; Bittner RE; Mylonas G; Roberts PK; Zotter S; Baumann B; Pircher M; Hitzenberger CK; Schmidt-Erfurth UM; Ritter M Retina; 2019 Mar; 39(3):558-569. PubMed ID: 29215532 [TBL] [Abstract][Full Text] [Related]
2. Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with best vitelliform macular dystrophy. Kay CN; Abramoff MD; Mullins RF; Kinnick TR; Lee K; Eyestone ME; Chung MM; Sohn EH; Stone EM Arch Ophthalmol; 2012 Mar; 130(3):357-64. PubMed ID: 22084158 [TBL] [Abstract][Full Text] [Related]
3. Optical Coherence Tomography Examination of the Retinal Pigment Epithelium in Best Vitelliform Macular Dystrophy. Qian CX; Charran D; Strong CR; Steffens TJ; Jayasundera T; Heckenlively JR Ophthalmology; 2017 Apr; 124(4):456-463. PubMed ID: 28187978 [TBL] [Abstract][Full Text] [Related]
4. Multimodal Imaging in Best Vitelliform Macular Dystrophy. Lima de Carvalho JR; Paavo M; Chen L; Chiang J; Tsang SH; Sparrow JR Invest Ophthalmol Vis Sci; 2019 May; 60(6):2012-2022. PubMed ID: 31070670 [TBL] [Abstract][Full Text] [Related]
5. Clinical Correlation Between Optical Coherence Tomography Biomarkers and Retinal Sensitivity in Best Vitelliform Macular Dystrophy. Battaglia Parodi M; Bianco L; Arrigo A; Saladino A; Antropoli A; Pina A; Marchese A; Aragona E; Rashid HF; Bandello F Transl Vis Sci Technol; 2022 Sep; 11(9):24. PubMed ID: 36156730 [TBL] [Abstract][Full Text] [Related]
6. Quantitative fundus autofluorescence and optical coherence tomography in best vitelliform macular dystrophy. Duncker T; Greenberg JP; Ramachandran R; Hood DC; Smith RT; Hirose T; Woods RL; Tsang SH; Delori FC; Sparrow JR Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1471-82. PubMed ID: 24526438 [TBL] [Abstract][Full Text] [Related]
7. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging. Ritter M; Zotter S; Schmidt WM; Bittner RE; Deak GG; Pircher M; Sacu S; Hitzenberger CK; Schmidt-Erfurth UM; Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6416-25. PubMed ID: 23882696 [TBL] [Abstract][Full Text] [Related]
9. INTRARETINAL HYPERREFLECTIVE FOCI IN BEST VITELLIFORM MACULAR DYSTROPHY. Parodi MB; Romano F; Sacconi R; Casati S; Marchini G; Bandello F; Iacono P Retina; 2018 Dec; 38(12):2379-2386. PubMed ID: 29065010 [TBL] [Abstract][Full Text] [Related]
10. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES IN DIFFERENT STAGES OF BEST VITELLIFORM MACULAR DYSTROPHY. Battaglia Parodi M; Iacono P; Romano F; Bandello F Retina; 2018 May; 38(5):1041-1046. PubMed ID: 28376040 [TBL] [Abstract][Full Text] [Related]
11. Multimodal imaging in Best Vitelliform Macular Dystrophy: Literature review and novel insights. Bianco L; Arrigo A; Antropoli A; Berni A; Saladino A; Vilela MA; Mansour AM; Bandello F; Battaglia Parodi M Eur J Ophthalmol; 2024 Jan; 34(1):39-51. PubMed ID: 36972471 [TBL] [Abstract][Full Text] [Related]
19. Findings of Optical Coherence Tomography Angiography in Best Vitelliform Macular Dystrophy. Wang XN; You QS; Li Q; Li Y; Mao Y; Hu F; Zhao HY; Tsai FF; Peng XY Ophthalmic Res; 2018; 60(4):214-220. PubMed ID: 29656284 [TBL] [Abstract][Full Text] [Related]